Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2009-5-12
pubmed:abstractText
Anemia remains an early and common complication of chronic kidney disease that causes troubling symptoms and reduced quality of life. Recent literature has raised concern about the safety of erythropoiesis-stimulating agent (ESA) treatment to higher hemoglobin targets, making this an ideal time to review this subject. In addition, new drugs are being developed in both the ESA and intravenous (i.v.) iron classes.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
1535-3842
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
18
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
112-5
pubmed:meshHeading
pubmed:year
2009
pubmed:articleTitle
Anemia in chronic kidney disease: status of new therapies.
pubmed:affiliation
Winthrop University Hospital, Mineola, New York, USA.
pubmed:publicationType
Journal Article, Review